Zepbound · Tirzepatide

Zepbound Coupons and Savings (2026 Guide)

Every active Zepbound discount, compared side by side. Updated monthly.

BBB AccreditedMedically reviewed byDr. Golsa Gholampour, MDLast updated2026-04-19
Quick answer

The lowest Zepbound out-of-pocket price in 2026 is $25 per month via the Lilly Savings Card for patients with commercial insurance that covers Zepbound. Without insurance, LillyDirect Self Pay costs $299 to $449 per month for vials and the new Multi-Dose KwikPen. Income-qualified uninsured patients may qualify for free or reduced access through the Lilly Cares Patient Assistance Program. Medicare, Medicaid, Tricare, VA, and DOD plans are excluded from manufacturer coupons by law, though the November 2025 Most-Favored-Nation pricing framework is expected to change that.

Section 1

Active Zepbound savings in 2026

Four programs, compared across eligibility, monthly cost, and how to claim. Prices verified this month.

Program
Lilly Savings Card (covered)★ Best deal
Manufacturer program
Who qualifies
Commercial insurance, Zepbound covered on plan
Excludes Medicare, Medicaid, Tricare, VA, DOD.
Monthly cost
As low as $25/monthFor 1-month, 2-month, or 3-month supply. Month defined as 28 days, up to 4 pens.
Program
Lilly Savings Card (not covered)
Manufacturer program
Who qualifies
Commercial insurance, Zepbound NOT covered
Excludes Medicare, Medicaid, Tricare, VA, DOD.
Monthly cost
Up to $650/month in savingsExact out-of-pocket varies by dose, pharmacy, and monthly/annual program caps.
Program
LillyDirect Self Pay (Zepbound Self Pay Journey Program)
Direct-from-manufacturer (cash pay)
Who qualifies
Anyone without insurance or without coverage, prescription required
Monthly cost
$299 to $449 depending on dose (promotional pricing, ongoing)Promotional Zepbound Self Pay Journey Program active since Feb 23, 2026. Prices below reflect current promo rates.
Program
Lilly Cares Patient Assistance Program
Patient Assistance Program
Who qualifies
Income-qualified uninsured patients
Monthly cost
Free or reducedSubject to annual income limits (typically tied to Federal Poverty Level).
List price without any program: $1086.37 per month at the highest dose. All savings reference this baseline.
Section 2

Which savings program fits you?

Start with your insurance status. Each branch ends at the lowest legal path available to you today.

1
Branch 1
Commercial insurance, Zepbound covered
Employer, ACA marketplace, or private plan with Zepbound on formulary
2
Branch 2
Commercial insurance, Zepbound not covered
Plan excludes GLP-1 weight-loss medications
ATry Savings Card anyway (non-covered rate)

Consider requesting a formulary exception first. Appeal process may unlock full coverage.

3
Branch 3
Medicare / Medicaid / Tricare / VA (current)
Federal or state-funded plans, before April 2026 Medicare rollout
AIf income-qualified

Savings Card is excluded for federal plans. Medicare coverage may begin as early as April 2026 per Trump administration announcement (Nov 2025). MFN pricing framework would cap Medicare copays at ~$50/mo. Medicaid coverage for obesity varies: 13 states cover GLP-1 drugs for obesity as of Jan 2026.

4
Branch 4
Uninsured / Cash pay
No current prescription drug coverage
Section 3

A note on compounded tirzepatide

⚠ Legal status changed

FDA declared the tirzepatide shortage resolved in late 2024. As of 2025-2026, pharmacies are no longer permitted to regularly compound tirzepatide injections. Narrow exceptions exist for documented patient-specific medical needs (e.g., allergy to inactive ingredients in commercial Zepbound).

Beware of counterfeit tirzepatide or providers claiming to offer compounded tirzepatide without documented patient-specific medical need. This is now a legal gray area with real safety risk.

Use LillyDirect Multi-Dose KwikPen ($299-$449) as the current primary cash-pay path. Compounded tirzepatide is no longer a reliable cost-saving option.

Section 4

Frequently asked questions

Every question patients ask most often about Zepbound coupons and savings.

No. Federal insurance programs (Medicare, Medicaid, Tricare, VA, DOD) are explicitly excluded from the Lilly Savings Card by law. This is true of nearly all manufacturer copay cards. If you have Medicare Part D, coverage of GLP-1 medications for obesity begins rolling out in July 2026. A federal Most-Favored-Nation pricing framework announced in November 2025 is expected to cap Medicare copays at around $50/month for eligible enrollees, with Zepbound reportedly available at approximately $346/month on a government discount platform.
Find your cheapest option

Not sure which option is right for you?

Take our 90-second quiz. We match you to the lowest-cost Zepbound path based on your insurance, location, and medical history.

Methodology & medical review

Pricing verified against Lilly's official pricinginfo.lilly.com page, cross-referenced with Noom Med (March 2026), GoodRx, and Drugs.com. We do not accept payment for inclusion in any comparison. Medical content reviewed by Dr. Golsa Gholampour, MD, board-certified in obesity medicine. Quarterly re-verification scheduled.

Medically reviewed by Dr. Golsa Gholampour, MD
Reviewed 2026-04-19. Pricing last verified 2026-04-19.